Study S003196

Evidence-Based Longevity Interventions and Targeted Engagement (E.L.I.T.E.)

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07871799
Acronym: ELITE
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: NONE
Status: COMPLETED
Enrollment: 31
Start: 2025-11-17
Primary completion: 2026-02-25
Lead sponsor: Sheba Medical Center
Conditions: Healthy Aging
Interventions: DIETARY_SUPPLEMENT:AgeBiotics AB-01; DIETARY_SUPPLEMENT:AgeBiotics AB-02; DRUG:Metformin; DRUG:semaglutide; DRUG:empagliflozin
Results posted: FALSE
Individual participant data sharing: NO
Secondary identifiers: REGISTRY:MOH_2026-07-21_016947; REGISTRY:ISRCTN84791030

Registered primary outcomes

Change From Baseline in Muscular-Immune-Cognitive Composite (MIC-C) Score at Week 8 [Baseline to Week 8]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.